In 2006, revenues in the total RNAi market amounted to approximately $85.1 million. Revenues were generated from the sales of content, delivery tools, and screening and analysis tools. Sales of ...

RNAi (RNA interference) and CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) screening are two powerful techniques at the forefront of functional genomics research. Both techniques ...

Global genetic pattern analysis using cDNA microarray-based CGH for prognosis prediction to FAC neoadjuvant and adjuvant chemotherapy in locally advanced breast cancer patients Treatment of cancer ...

La Jolla Labs was founded to make modern RNA biology and advanced computational techniques directly useful to patients whose ...

First-of-its-kind 1,000-patient clinical study will use RNA-based stool and saliva tests to detect colon polyps — early warning signs of colorectal cancer — before they become cancerous. Study aims to ...

The discovery of RNAi dates back to the 1990s when researchers observed unexpected gene silencing in plants and fungi. In 1998, Andrew Fire and Craig Mello published a groundbreaking study ...

CRISPR-based technologies promise transformative therapies, yet their success depends on the purity and quality of guide RNAs (gRNA). During high-throughput screening of candidates, even small ...

Lethal and rescuer genes are defined as genes that when inactivated result in cell death or enhanced cell growth, respectively. The ability to identify these genes in large-scale automated screening ...

ST. LOUIS--(BUSINESS WIRE)--Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, today announced that the U.S. Food and Drug ...